208 results about "Continuous delivery" patented technology

A system and method for continuously monitoring and updating delivery schedules based on completed deliveries and customer modifications. A delivery scheduling computer stores and updates delivery schedule information, notifying the customer prior to a scheduled delivery of an estimated time of delivery. The notification is made to a customer's PC, browser-based client, hand-held computer or set-top box, or by conventional communication methods such as a telephone, pager, or cellular phone. If the customer desires to change the time or location of the delivery, the customer transmits a delivery change request and the schedule is modified accordingly. Employees use a hand-held computer or a browser-based client to receive updated delivery schedule information, as well as to transmit a delivery completion message to the delivery scheduling computer. The message includes an actual delivery time which the delivery scheduling computer uses to update the estimated delivery times of the remaining deliveries.

An implantable device includes a reservoir containing a suspension of an interferon in an amount sufficient to provide continuous delivery of the interferon at a therapeutically effective rate of 1 ng/day to 600 μg/day to maintain and achieve therapeutic blood or plasma levels of the interferon throughout a substantial period of the administration period.

A system and method for mixing and delivering fluids such as contrast media and saline is disclosed including at least two fluid sources, a pump, a joining fluid path connecting the at least two fluid sources to an inlet to the pump, and a valve device in the fluid path upstream of the pump. The valve device includes an actuator adapted to restrict flow in at least one of respective fluid lines connecting the at least two fluid sources to the pump inlet. A patient interface device may be associated with an outlet of the pump. The valve device actuator is generally adapted to restrict the flow in at least one of the respective fluid lines such that an incremental positional change in valve device actuator position provides a substantially linear change in fluid mixture ratio of the fluids from the at least two fluid sources to the pump inlet.

The invention provides a microservice application arrangement and deployment method and device and a computer terminal. The method comprises the steps of reading a dependency tree of a pre-stored microservice application, wherein the microservice application is a root node of the dependency tree; traversing all nodes in the dependency tree according to a preset rule and determining a starting sequence of all nodes; and deploying applications corresponding to all nodes to an operation environment according to the starting sequence, thereby finishing deploying the microservice application. According to the method, the device and the computer terminal, the condition that a user directly writes a complex program to realize the arrangement and deployment of the applications is avoided, a plurality of sets of environments for operating microservice are set up rapidly, the continuous integration, continuous delivery and continuous deployment are facilitated, all applications are deployed through a key, and a technical level of an enterprise is improved.

The present invention is directed to treatment methods for a disease or condition, in a subject in need of such treatment, that provide alternatives to treatment by injection that give, relative to treatment by injection, improved treatment outcomes, 100% treatment compliance, reduced side effects, and rapid establishment and/or termination of substantial steady-state drug delivery. The method typically includes providing continuous delivery of a drug from an implanted osmotic delivery device, wherein substantial steady-state delivery of the drug at therapeutic concentrations is typically achieved within about 7 days or less after implantation of the osmotic delivery device in the subject and the substantial steady-state delivery of the drug from the osmotic delivery device is continuous over a period of at least about 3 months. In one embodiment, the present invention is directed to treatment of type 2 diabetes mellitus using incretin mimetics.

Embodiments of the invention are directed to a system, method, or computer program product for integrated development and operations solution. The claimed invention aims to automate the implementation of deploying software from development to production by leveraging familiar processes and technologies to increase communication and collaboration between the development and operations teams. Further, the claimed invention enables continuous delivery of change by providing visibility into the status change in all environments, insight into release/change status (delays, cancellations, or the like), enabling quality driven change progression and will consolidate tools as appropriate.

A hydraulic pumping system is provided for delivering a compressible fluid material from a hopper to an outlet. A primary hydraulically driven pumping unit has a first interior volume for receiving the fluid material from the hopper. A secondary hydraulically driven pumping unit is interconnected with the primary hydraulically driven pumping unit and has a second interior volume less than the first interior volume for receiving fluid material from the primary hydraulically driven pumping unit. The primary and secondary hydraulically driven pumping units have hydraulically driven reciprocating piston units with unequal stroke lengths. The piston units are alternately reciprocated to fill the first interior volume of fluid material from the hopper, pump a portion of the first interior volume of fluid material into the second interior volume and the remainder of the first interior volume to the outlet, and pump the second interior volume of fluid material to the outlet while fluid material is being pulled into the first interior volume in a sequential and simultaneous manner which will produce substantially continuous delivery of fluid material to the outlet.

The invention discloses a software quality assurance method integrating continuous delivery and automated test, The method provides users with the function of individually customizing the software quality detection pipeline, which is composed of source code configuration, static code scanning, continuous construction, continuous deployment, functional testing, performance testing, compatibility testing and dynamic security testing. By using the software quality assurance system, Testers do not need to build a complex continuous integration and testing environment, and can quickly implement automated testing of each dimension of a project, or predefine a software quality inspection pipeline for automated testing, and provide the overall test results of the entire project, which greatly improves the test efficiency and reduces the complexity of test configuration.

A method and apparatus for isolating and/or eliminating RFI, EMI, and noise transients in power supply circuits. The circuit isolates DC to DC and AC to DC power coupling by use of dual, parallel current paths that are alternately gated. The gating of the switches is controlled by a control module, which ensures that the input and output of the circuit is electromagnetically blocked during any instant in time, while simultaneously ensuring proper and continuous delivery of current to the circuit output load.

The present invention is directed to treatments for a disease or condition, in a subject in need thereof, that provide alternatives to treatment by injection that give, relative to treatment by injection, improved treatment outcomes, 100% treatment compliance, reduced side effects, and rapid establishment and/or termination of substantial steady-state drug delivery. The method includes providing continuous delivery of a drug from an implanted osmotic delivery device, wherein substantial steady-state delivery of the drug at therapeutic concentrations is achieved within about 7 days after implantation of the osmotic delivery device in the subject and the substantial steady-state delivery of the drug from the osmotic delivery device is continuous over a period of at least about 3 months. In one embodiment, the present invention is directed to treatment of type 2 diabetes mellitus using insulinotrophic peptides. In embodiments, a subject has a baseline HbA1c % of greater than 6.5% or 10.0%.

The invention discloses an automatic gray scale publishing method, system and device based on a container platform. The method comprises the steps of conducting pre-deploying configuration on new-version software; when a new-version mirror image is monitored, generating the new-version software; according to the pre-deployed configuration, distributedly deploying the new-version software to a cluster in the form of a pod of a K8S system. By means of the automatic gray scale publishing method, system and device, the new-version software is automatically deployed to the cluster, service codes donot need to be embedded, multiplex environments do not need to be maintained either, gray scale publishing can be completed in a production environment or a testing environment, and can be combined with a continuous delivery flow simply through the simple configuration, the workload can be effectively reduced, and the development efficiency is greatly improved. The automatic gray scale publishingmethod, system and device can be widely applied to software developing.

A method and apparatus for fluid delivery enables navigation through tortuous, spatially restricted body anatomy to access narrow diameter body lumens for the continuous delivery of fluids, including therapeutic fluids, to the lumen in an atraumatic manner that avoids damage to the body lumen. The fluid delivery device can have a flexible conduit having a proximal end, a distal end, and a lumen extending along an interior of the flexible conduit providing a fluid flow path between the proximal and distal ends, where the lumen transitions into a micro-lumen exiting through a port through which a high concentration of fluid injected into the lumen exits laterally out along an image viewable zone at the distal end of the flexible conduit. The flexible conduit has a maximum outer diameter sized sufficient to navigate narrow diameter body lumens.

Microcatheter for delivering a substance (e.g., infusion agent including embolization material and/or contrast enhancing material) in a small blood vessel towards a target bodily part. Includes a single lumen surrounded by tubular wall having outer diameter and opened at both ends; tubular wall proximal portion is connectable to a pressure source and reservoir containing infusion agent, and tubular wall distal portion ends with a tip; the tubular wall distal portion includes an infusion agent flow disruption section configured to disrupt passage therethrough of incoming retrograded flow of infusion agent, during continuous delivery of infusion suspension from the reservoir to the tip. Disclosed are methods using the microcatheter for performing local embolization in a small blood vessel feeding a (for example, cancerous) target bodily part, and for delivering infusion agent in a small blood vessel towards such target bodily part. Also disclosed are devices and methods for filtering non-target infusion agent.

The invention relates to a multi-cylinder thick matter pump (1) which is used to continuously deliver especially concrete. Said thick matter pump comprises at least two delivery cylinders (3, 5) which transport the thick matter from a prefill tank (7) into a delivery pipe and a reversing valve (9) for alternately linking the delivery cylinders with the delivery pipe. The invention is characterized in that the reversing valve (9) comprises two pilot valves (15, 17) which can be displaced in a substantially translatory manner. Every pilot valve (15, 17) comprises a straight pipe section (15L, 17L) for linking the respective assigned delivery cylinder (3, 5) with the delivery pipe. Said pipe section can be linked with a manifold (19) in a pipe position downstream of the delivery cylinder. The invention also relates to a method for operating the inventive thick matter pump for continuous delivery.

A system and method for CI/CT/CD, which is continuous integration/continuous testing/continuous delivery, in which testing is fully integrated to the needs of rapid code development and delivery. The system is determining test coverage of a plurality of tests, comprising a code builder for providing code, a code tester for testing the code with said plurality of tests, and a code test analyzer for analyzing results of said plurality of tests to determine coverage of said code by said plurality of tests.